(RTTNews) - UCB and Biogen Inc. (BIIB) presented detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol, a Fc-free anti-CD40L drug candidate, showing significant clinical ...
Mizkan America, the maker of Ragu spaghetti sauce and other specialty foods, will soon move its headquarters to northwest suburban Schaumburg.
Needham analyst Ami Fadia downgraded Biogen (BIIB) to Hold from Buy.Don't Miss our Black Friday Offers:Discover the latest stocks recommended ...
“We have designed this initiative to ensure that over time, many of these units will be replaced by new restaurants at better locations with significantly improved sales and profitability,” he ...
Wendy’s will be closing 140 restaurants across the country but said that it will be opening an equal number of locations. The new locations will be in areas that can generate more business, the ...
Here’s what you need to know. On Thursday, Wendy’s announced its Q3 2024 results and revealed it would be closing 140 locations by the end of 2024. Wendy’s president and chief executive ...
the publisher gave key updates on the new international tournament and the locations for the three global events for season 15. With the introduction of the new tournament, there will be more chances ...
The grocer first announced the closure of 32 "underperforming" stores in July, saying shuttering the nearly three dozen Northeastern locations will "position the company for growth." Shutting down ...
Q3 2024 Earnings Call Transcript October 30, 2024 Biogen Inc. misses on earnings expectations. Reported EPS is $ EPS, expectations were $3.77. Operator: Good morning. My name is Cynthia, and I will be ...
Biogen Inc. ( (BIIB)) has realeased its Q3 earnings. Here is a breakdown of the information Biogen Inc. presented to its investors. Biogen Inc. is a leading biotechnology company that specializes ...
Bio­gen’s in­vestors are grow­ing rest­less. Wednes­day’s third-quar­ter earn­ings call checked most of the box­es for a suc­cess­ful re­port. The com­pa­ny raised its full-year ...
Despite a somewhat ambling launch, Biogen’s Eisai-partnered Alzheimer ... McDonnell pointed to a recent decision from the European Patent Office to uphold a Tecfidera patent concerning dimethyl ...